LIFEMINE Trademark

Trademark Overview

On Friday, June 11, 2021, a trademark application was filed for LIFEMINE with the United States Patent and Trademark Office. The USPTO has given the LIFEMINE trademark a serial number of 90770169. The federal status of this trademark filing is REGISTERED as of Tuesday, December 9, 2025. This trademark is owned by LIFEMINE THERAPEUTICS, INC.. The LIFEMINE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Research, development in the medical, pharmaceutical and biotechnology fields; research and development in the field of the biosphere, fungi, pharmaceuticals and therapeutics

Pharmaceuticals, namely, preparations for the treatment of infections, cancer, and autoimmune diseases; pharmaceuticals using genetic code to target and treat diseases in humans, namely, preparations for the treatment of infections, cancer, and autoimmune diseases
lifemine

General Information

Serial Number90770169
Word MarkLIFEMINE
Filing DateFriday, June 11, 2021
Status700 - REGISTERED
Status DateTuesday, December 9, 2025
Registration Number8060972
Registration DateTuesday, December 9, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2022

Trademark Statements

Pseudo MarkLIFE MINE
Goods and ServicesResearch, development in the medical, pharmaceutical and biotechnology fields; research and development in the field of the biosphere, fungi, pharmaceuticals and therapeutics
Goods and ServicesPharmaceuticals, namely, preparations for the treatment of infections, cancer, and autoimmune diseases; pharmaceuticals using genetic code to target and treat diseases in humans, namely, preparations for the treatment of infections, cancer, and autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 1, 2021
Primary Code005
First Use Anywhere DateTuesday, September 30, 2025
First Use In Commerce DateTuesday, September 30, 2025
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 1, 2021
Primary Code042
First Use Anywhere DateSaturday, September 30, 2017
First Use In Commerce DateThursday, August 31, 2017

Trademark Owner History

Party NameLIFEMINE THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameLIFEMINE THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameLIFEMINE THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02140

Trademark Events

Event DateEvent Description
Tuesday, June 15, 2021NEW APPLICATION ENTERED
Wednesday, September 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 2, 2022ASSIGNED TO EXAMINER
Wednesday, March 2, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 2, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 10, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 30, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 30, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, April 22, 2023SOU TEAS EXTENSION RECEIVED
Saturday, April 22, 2023SOU EXTENSION 1 FILED
Saturday, April 22, 2023SOU EXTENSION 1 GRANTED
Tuesday, April 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 25, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 25, 2023SOU EXTENSION 2 FILED
Monday, September 25, 2023SOU EXTENSION 2 GRANTED
Wednesday, September 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 19, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 19, 2024SOU EXTENSION 3 FILED
Tuesday, March 19, 2024SOU EXTENSION 3 GRANTED
Wednesday, March 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 12, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 12, 2024SOU EXTENSION 4 FILED
Thursday, September 12, 2024SOU EXTENSION 4 GRANTED
Thursday, September 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 10, 2025SOU TEAS EXTENSION RECEIVED
Monday, July 7, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, March 9, 2025SOU EXTENSION 5 FILED
Monday, July 7, 2025SOU EXTENSION 5 GRANTED
Monday, July 7, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 21, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, October 21, 2025USE AMENDMENT FILED
Wednesday, October 22, 2025STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 19, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 19, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, November 19, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 19, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 9, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, December 9, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

lifemine pharmaceuticals diseases preparations research treatment cancer autoimmune infections namely development